SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as market participants debate whether recent price consolidation and integration with financial infrastructure point to a breakout or a prolonged period of manipulation. The community remains deeply polarized, with long-term holders focusing on institutional adoption and potential regulatory clarity, while critics highlight the token's large supply and price correlation with broader market movements.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is facing intense bearish pressure and sentiment, with investors expressing significant frustration over consistent downward price action despite positive earnings and strategic partnerships like the recent Mastercard stablecoin deal. Many in the community are debating whether to hold through the volatility as a long-term fintech play or to capitulate, while others suggest the stock is being heavily suppressed by short sellers and broader macroeconomic fears surrounding private credit and geopolitical conflict.

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

CytomX Therapeutics Inc

CytomX Therapeutics is trending following a massive volume surge and significant price action fueled by positive expansion data for its Varseta-M candidate in colorectal cancer, which has led multiple analysts to raise their price targets. The community is heavily focused on the drug's potential as a clinical game-changer, while active traders continue to debate the balance between its promising pipeline, recent institutional accumulation, and the lingering threat of future stock dilution.

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate Inc. is trending as investors accumulate shares ahead of critical upcoming catalysts, including a highly anticipated U.S. patent approval and a May 31, 2026, PDUFA date for its ADHD treatment, CTx-1301. The community is focused on the stock's low-float structure and recent institutional filings, with many debating the potential for a significant breakout driven by the company's proprietary delivery platform and a massive addressable market.

Better Home & Finance Holding Co. engages in the provision of comprehensive homeownership services. It offers mortgage loans, real estate agent services, and title and homeowner's insurance services. The company was founded in 2014 and is headquartered in New York, NY.

Better Home & Finance Holding Co. - Ordinary Shares - Class A

Better Home & Finance Holding Co.

Better Home & Finance is currently experiencing significant market volatility as investors weigh the potential for a short squeeze against concerns over insider selling and the unwinding of recent momentum. The community is actively debating the company's long-term potential as an AI-driven mortgage platform, with many monitoring its evolving institutional ownership and partnerships despite the stock's recent price retracement.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore (SOC) is in focus after receiving a federal order under the Defense Production Act to resume hydrocarbon transportation through the Santa Ynez Pipeline System, fueling intense discussion about a potential short squeeze given high short interest. While the community is debating the impact of federal versus state legal friction, many are optimistic about the upcoming target for first oil sales and future production capacity.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is currently trending due to a surge in market activity and institutional positioning, with investors closely watching the company ahead of its upcoming earnings report. The community is actively debating the credibility of recent acquisition rumors, while closely monitoring the potential impact of new long-acting pipeline data on the company's valuation.

Crane Harbor Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on January 2, 2025 and is headquartered in Philadelphia, PA.

Crane Harbor Acquisition Corp. - Ordinary Shares - Class A

Crane Harbor Acquisition Corp.

Crane Harbor Acquisition Corp. is trending as investors rally behind its pending merger with Xanadu Quantum Technologies, a pioneer in photonic quantum computing with high-profile strategic partnerships like AMD, Lockheed Martin, and Rolls-Royce. The community is closely tracking the upcoming shareholder vote and potential government funding, with many noting that the company's hardware-agnostic software platform, PennyLane, is already a dominant force in quantum development.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital is currently trending as investors await a long-anticipated tenant announcement for its data center projects, with community sentiment divided between bullish confidence in the company's energy infrastructure and frustration over repeated delays. Traders are actively debating the impact of recent SEC filings and speculating on the identity of a potential hyperscale tenant, while the stock continues to see high volatility driven by speculative momentum.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is currently experiencing significant market momentum following a major AI infrastructure agreement with Meta, which investors see as a massive validation of its platform's growth trajectory and long-term potential. While the community is actively debating the stock's future valuation and long-term outlook, many are focused on the company's ability to scale high-performance computing capacity as a primary driver for the current bullish sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Anixa Biosciences (NASDAQ:ANIX) Lowered to "Sell" Rating by Wall Street Zen

Wall Street Zen lowered shares of Anixa Biosciences from a "hold" rating to a "sell" rating in a research report on Sunday...

Anixa Biosciences AGM: Shareholders Back Directors as CEO Highlights CAR-T, Vaccine Progress

Anixa Biosciences (NASDAQ:ANIX) held its 2026 Annual Meeting of Stockholders via live webcast, outlining the results of shareholder votes and providing an operational update focused on the company's...

Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast

Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast PR Newswire SAN JOSE, Calif., March...

Anixa Biosciences (NASDAQ:ANIX) Posts Earnings Results, Beats Expectations By $0.01 EPS

Anixa Biosciences (NASDAQ:ANIX - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.01...

Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology

Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology Anixa Biosciences Receives Notice of Allowance...

Anixa Biosciences (NASDAQ:ANIX) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded Anixa Biosciences from a "sell" rating to a "hold" rating in a research note on Saturday...

Anixa Biosciences (ANIX) to Release Earnings on Tuesday

Anixa Biosciences (NASDAQ:ANIX) will be releasing its Q1 2026 earnings before the market opens on Tuesday, March 10. (View Earnings Report at...

Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress

Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress Anixa Biosciences to Host 2026 Annual Meeting of...

Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Recommendation of "Hold" by Analysts

Shares of Anixa Biosciences Inc (NASDAQ:ANIX - Get Free Report) have been assigned an average recommendation of "Hold" from the five brokerages that are covering the company, MarketBeat.com reports...

Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat

Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat Anixa Biosciences Announces Dr. Jose Conejo-Garcia will...

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The CAR-T Therapeutics segment is involved in the development of immuno-therapy drugs against cancer. The Other segment refers to its legacy operations, including patent licensing. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

ANIX
Anixa Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ANIX News

ANIXAnixa Biosciences Inc